The Oncology Institute (TOI) announced that it has been selected to present an abstract at the upcoming ASCO Annual Meeting further validating cost savings and reduced hospitalizations associated with its High-Value Cancer Care model. The study shares new data supporting prior publications which demonstrate superior outcomes for acute-care patients when enrolled in the TOI HVCC model. Summary of Outcomes of the Most Recent Clinical Trial Analysis: 53% Lower Emergency Department Use; 68% Lower Hospitalizations; 75% Lower Odds of Acute Care Facility Death; Lower Total Cost of Care by $12,000 per Enrolled Patient
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.